New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

BPH Global Raises $130,000 in Debt Funding

July 31, 2024

Heliostar Delivers Strong First Quarter 2025 Results

April 28, 2025

Panelists: Hard Assets Key as Geopolitical Shifts Reshape...

February 3, 2025

Odessa Minerals Limited (ASX: ODE) – Trading Halt

September 26, 2024

​Tech 5: Aide Says Harris Supports Policies to...

August 25, 2024

UAE the Top Destination for Smuggled African Gold...

June 4, 2024

South Star Battery Metals Announces Closing of Tranche...

March 8, 2024

BTR commences Fish Mine on schedule and under...

April 9, 2025

Grid Battery Metals Team Provides Nevada Exploration Update...

February 8, 2024

Significant Citizen Interest in the Immersive Workshop

July 18, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Colombian model’s murder, just days after Mexican influencer shot on live stream, sparks condemnation of femicide

      May 19, 2025

    • Israel begins extensive Gaza ground operation after intense airstrikes kill more than 100 overnight

      May 19, 2025

    • These dragon’s blood trees exist in only one place on Earth. Now their survival is under threat

      May 19, 2025

    • Polish centrist and nationalist presidential candidates to face off in 2nd round

      May 19, 2025

    • Portugal’s ruling center-right alliance wins election, but far-right makes record gains

      May 19, 2025

    • Tanzanian opposition leader appears in court for treason trial

      May 19, 2025

    Popular

    • 1

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 2

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 3

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023
    • 4

      Americans are starting to feel better about the economy and inflation

      December 13, 2023
    • 5

      Rare Earths Stocks: 8 Biggest Companies in 2024

      January 12, 2024
    • 6

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 7

      Investing in Graphene Companies

      May 9, 2024

    Categories

    • Business (1,322)
    • Investing (3,130)
    • Politics (4,115)
    • World (4,067)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved